Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pacific Biosciences (NQ: PACB )

13.81 -0.16 (-1.15%)
Streaming Delayed Price Updated: 11:06 AM EDT, Jun 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,061,351
Open 13.91
Bid (Size) 13.80 (11)
Ask (Size) 13.81 (7)
Prev. Close 13.97
Today's Range 13.56 - 14.00
52wk Range 3.850 - 14.20
Shares Outstanding 247,079,374
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Where Pacific Biosciences Stands With Analysts
 
Via Benzinga
Market Mixes It Up With A Broad Rally
Biotech stocks remain sluggish but the longer-term outlook for breakthrough therapies - gene therapy, obesity, CNS, RNA - remain positive. 
Via Talk Markets

Performance

YTD
+73.93%
+73.93%
1 Month
+12.73%
+12.73%
3 Month
+55.17%
+55.17%
6 Month
+48.49%
+48.49%
1 Year
+182.99%
+182.99%

More News

Read More
Time To Play Small Cap Life Science Stocks
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023
Via Benzinga
Expert Ratings for Pacific Biosciences
Via Benzinga
Pacific Biosciences (NASDAQ: PACB) Making Surprising Moves in Friday Session
Via Investor Brand Network
Earnings Scheduled For February 16, 2023
Via Benzinga
Something Happened In Biotech Last Week
Via Talk Markets
Cathie Wood Scoops Up AMD Stock On A Day When It Tanks Over 9%: Also Raises Stake In This Biotech Company
Via Benzinga
Small & Mid Cap Life Science Stock Portfolio: Some Good Picks In A Stalled Sector
Via Talk Markets
Consolidated Communications, CRISPR Therapeutics And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Earnings Outlook For Pacific Biosciences
Via Benzinga
Biotech And Life Science Trades: Q1 2023 Performance By The Numbers
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023
Via Benzinga
Rumble, TORM And Other Big Stocks Moving Higher In Friday's Pre-Market Session
Via Benzinga
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
Via InvestorPlace
SMID Cap Life Science Update: Are You An Investor Or Trader?
Via Talk Markets
Why Bionano Genomics, Pacific Biosciences of California, and Sangamo Therapeutics Stocks Crumbled This Week
Via The Motley Fool
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
Via Talk Markets
Why Pacific Biosciences Of California Shares Are Trading Higher Today
Via Benzinga
Sea, UiPath, J&J Snack Foods And Other Big Gainers From Tuesday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
Via Benzinga
Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday
Via Benzinga
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Pacific Biosciences's Earnings: A Preview
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.